中文

迈克生物 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-29
ItemAmountY/Y
Revenue¥0.48B-6.9%
Gross profit¥0.27B
Operating income¥0.01B
Net income¥0.01B-74.1%
Gross margin57.7%Net margin 1.4%
Revenue Q/Q-15.5%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.20B42.3%
R&D¥0.07B14.9%
SG&A¥0.19B39.7%
Tax & other¥0.00B0.7%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

星徽股份高伟达赛摩智能迅游科技四方精创信息发展中密控股厚普股份*ST新元德尔股份景嘉微香农芯创

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies